Carbon Monoxide Neurotoxicity

CME/MOC: 1.0
TRACK: OEM Clinical Practice

Jeffrey Brent, MD, PhD, University of Colorado, School of Medicine, Aurora, CO
Jonathan Rutchik, MD, MPH, FACOEM, University of California, San Francisco, CA
David Schretlen, PhD, ABPP-CN, FAPA, Johns Hopkins University School of Medicine, Baltimore, MD

This session will introduce clinical vignettes of carbon monoxide exposures and will present the state of art for this evaluation, including history, physical examination findings, exposure assessment, and neuropsychological testing. The discussion will include the delayed neurological and neuropsychological syndrome, as well as the challenges of neurological and neuropsychological testing with the goals of presenting a guide to be able to confidently separate anxiety, depression, PTSD, progressive dementia, and true neuropsychological abnormality from common normal variant testing results.